Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Katja Weisel
Pomalidomide Plus Low-Dose Dexamethasone Versus High-Dose Dexamethasone Alone for Patients With Relapsed and Refractory Multiple Myeloma (MM-003): A Randomised, Open-Label, Phase 3 Trial
The Lancet Oncology
Oncology
High Cutoff Versus High-Flux Haemodialysis for Myeloma Cast Nephropathy in Patients Receiving Bortezomib-Based Chemotherapy (EuLITE): A Phase 2 Randomised Controlled Trial
The Lancet Haematology
Hematology
Once- Versus Twice-Weekly Carfilzomib in Relapsed and Refractory Multiple Myeloma by Select Patient Characteristics: Phase 3 A.R.R.O.W. Study Subgroup Analysis
Blood Cancer Journal
Oncology
Hematology
Mass Spectrometry-Based Identification of a B-Cell Maturation Antigen-Derived T-Cell Epitope for Antigen-Specific Immunotherapy of Multiple Myeloma
Blood Cancer Journal
Oncology
Hematology
Daratumumab-Based Regimens Are Highly Effective and Well Tolerated in Relapsed or Refractory Multiple Myeloma Regardless of Patient Age: Subgroup Analysis of the Phase 3 CASTOR and POLLUX Studies
Haematologica
Hematology
Rationale and Design of the German-Speaking Myeloma Multicenter Group (GMMG) Trial HD6: A Randomized Phase III Trial on the Effect of Elotuzumab in VRD Induction/Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma
BMC Cancer
Cancer Research
Oncology
Genetics